Skip to main content

Table 3 Health-related quality of life (HRQOL) scores according to physical activity levels among breast cancer survivors with stage I breast cancer

From: The association between physical activity and health-related quality of life among breast cancer survivors

HRQOL Items

Physical Activity (MET-hours per week)

All

Tertile 1

Tertile 2

Tertile 3

P for trenda

EORTC QLQ-C30, LS means (95% CI)b

Global health status / QoL

93

44.40 (27.04, 72.90)

33.27 (20.51, 53.98)

34.72 (20.75, 58.08)

0.35

Functioning

 Physical Functioning

101

74.97 (67.56, 83.20)

76.85 (69.59, 84.87)

84.62 (76.17, 94.00)

0.01

 Role Functioning

101

79.69 (60.00, 105.84)

71.11 (54.25, 93.20)

88.10 (66.14, 117.35)

0.36

 Emotional Functioning

101

83.73 (57.88, 121.12)

79.85 (56.16, 113.54)

80.11 (55.17, 116.33)

0.83

 Cognitive Functioning

101

77.91 (65.43, 92.78)

77.49 (65.61, 91.52)

67.46 (56.55, 80.48)

0.07

 Social Functioning

101

57.30 (39.62, 82.86)

70.40 (49.53, 100.07)

76.72 (52.85, 111.36)

0.12

Symptom

 Fatigue

101

27.95 (17.23, 45.34)

25.32 (15.97, 40.16)

16.29 (9.99, 26.55)

0.02

 Nausea / Vomiting

101

2.56 (1.15, 5.70)

2.75 (1.28, 5.89)

3.06 (1.37, 6.87)

0.64

 Pain

101

11.16 (4.92, 25.29)

7.64 (3.50, 16.65)

5.92 (2.59, 13.52)

0.12

 Dyspnea

99

5.25 (2.13, 12.96)

3.46 (1.46, 8.21)

4.02 (1.60, 10.13)

0.63

 Insomnia

101

14.61 (6.19, 34.49)

14.90 (6.57, 33.78)

22.14 (9.30, 52.72)

0.29

 Appetite loss

100

1.35 (0.54, 3.38)

2.04 (0.86, 4.84)

1.57 (0.63, 3.91)

0.85

 Constipation

101

3.70 (1.42, 9.67)

6.01 (2.41, 15.02)

8.35 (3.17, 22.04)

0.09

 Diarrhea

101

3.01 (1.36, 6.67)

2.27 (1.06, 4.84)

1.63 (0.73, 3.65)

0.12

 Financial Problems

101

2.82 (1.12, 7.07)

3.20 (1.33, 7.69)

1.92 (0.76, 4.86)

0.33

EORTC QLQ-BR23, LS means (95% CI)b

Functioning

 Body image

101

68.77 (39.53, 119.62)

65.36 (38.56, 110.80)

57.80 (33.04, 101.11)

0.51

 Sexual functioning

94

4.12 (1.54, 11.03)

4.56 (1.80, 11.54)

5.57 (2.12, 14.60)

0.50

 Sexual enjoyment

33

53.86 (7.89, 367.75)

36.75 (7.85, 172.11)

21.84 (3.57, 133.78)

0.25

 Future perspective

101

25.27 (10.25, 62.28)

30.21 (12.79, 71.39)

29.68 (11.93, 73.83)

0.75

Symptom

 Systematic therapy side effects

101

16.48 (10.39, 26.14)

15.77 (10.16, 24.48)

12.99 (8.15, 20.70)

0.27

 Breast symptoms

101

5.94 (3.08, 11.44)

6.82 (3.65, 12.74)

5.27 (2.72, 10.22)

0.63

 Arm symptoms

101

13.47 (7.64, 23.77)

13.75 (8.00, 23.62)

11.58 (6.52, 20.54)

0.55

 Upset by hair loss

69

14.10 (4.83, 41.22)

7.35 (2.41, 22.41)

15.16 (4.30, 53.40)

0.80

  1. MET metabolic equivalent, EORTC QLQ-C30 European organization for research and treatment of cancer quality of life questionnaire core 30, LS least-squares, CI confidence interval, EORTC QLQ-BR23 European organization for research and treatment of cancer quality of life questionnaire Breast cancer module 23
  2. aP for trend was calculated using the median value of each tertile category as a continuous variable
  3. bAdjusted for age (year: continuous), energy intake (kcal/day: continuous), dietary supplement use (yes, no), education level (high school or less, college or more), marital status (married or cohabitated, unmarried or divorced or widowed), time since surgery (6 month – 1 year, 1 year - 5 years, ≥5 years), and center
Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us